Atlas Trials

Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes

Clinical trial NCT01272193 · COMPLETED

Trial details

NCT number
NCT01272193
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2011-01-01
Primary completion
2011-09-01
Enrollment
296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.